Hot Features
プレミアム
Organon & Co (7XP)
TG
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-06 | Holzbaur LynetteSenior VP of Finance & Corporate Controller | -26.45k | 353.08k | 売り | 13.35 | 0.00 | -100.00% |
| 2026-03-31 | Ms. Juliana Papa DrinaneHead of Manufacturing & Supply | 10.82k | 0.00 | Derivative Exercise and Retained Stock | - | 33.24k | 48.24% |
| 2026-03-31 | Ms. Juliana Papa DrinaneHead of Manufacturing & Supply | -5.64k | 32.13k | Derivative Exercise and Sale | 5.70 | 33.24k | - |
| 2026-03-31 | Dr. Juan Camilo Arjona FerreiraExec. VP, Head of Research & Development and Chief Medical Officer | -4.82k | 27.47k | Derivative Exercise and Sale | 5.70 | 30.05k | - |
| 2026-03-31 | Dr. Juan Camilo Arjona FerreiraExec. VP, Head of Research & Development and Chief Medical Officer | 8.61k | 0.00 | Derivative Exercise and Retained Stock | - | 30.05k | 40.17% |
| 2026-03-31 | Mr. Daniel KarpChief Strategy Officer & Head of Corporate Development | -5.66k | 32.26k | Derivative Exercise and Sale | 5.70 | 69.55k | - |
| 2026-03-31 | Mr. Daniel KarpChief Strategy Officer & Head of Corporate Development | 12.39k | 0.00 | Derivative Exercise and Retained Stock | - | 69.55k | 21.69% |
| 2026-03-31 | Ms. Rachel A. StahlerExec. VP, Chief Information Officer and Chief Digital & Growth Officer | 12.40k | 0.00 | Derivative Exercise and Retained Stock | - | 116.11k | 11.96% |
| 2026-03-31 | Ms. Rachel A. StahlerExec. VP, Chief Information Officer and Chief Digital & Growth Officer | -6.46k | 36.84k | Derivative Exercise and Sale | 5.70 | 116.11k | - |
| 2026-03-31 | Mr. Matthew M. WalshExec. VP & CFO | 22.09k | 0.00 | Derivative Exercise and Retained Stock | - | 212.75k | 11.58% |
| 2026-03-31 | Mr. Matthew M. WalshExec. VP & CFO | -11.51k | 65.59k | Derivative Exercise and Sale | 5.70 | 212.75k | - |
| 2026-03-31 | Mr. Aaron FalcioneExec. VP & Chief HR Officer | -6.14k | 35.00k | Derivative Exercise and Sale | 5.70 | 101.43k | - |
| 2026-03-31 | Mr. Aaron FalcioneExec. VP & Chief HR Officer | 11.79k | 0.00 | Derivative Exercise and Retained Stock | - | 101.43k | 13.15% |
| 2026-03-31 | Mr. Kirke WeaverExec. VP, General Counsel & Corporate Secretary | 13.24k | 0.00 | Derivative Exercise and Retained Stock | - | 92.64k | 16.67% |
| 2026-03-31 | Mr. Kirke WeaverExec. VP, General Counsel & Corporate Secretary | -5.28k | 30.07k | Derivative Exercise and Sale | 5.70 | 92.64k | - |
| 2026-03-31 | Mr. Vittorio NisitaExec. VP and Head of Enterprise Services & Solutions | 8.55k | 0.00 | Derivative Exercise and Retained Stock | - | 70.62k | 13.77% |
| 2026-03-31 | Mr. Vittorio NisitaExec. VP and Head of Enterprise Services & Solutions | -4.45k | 25.38k | Derivative Exercise and Sale | 5.70 | 70.62k | - |
| 2026-03-31 | Holzbaur LynetteSenior VP of Finance & Corporate Controller | 7.84k | 0.00 | Derivative Exercise and Retained Stock | - | 26.40k | 42.24% |
| 2026-03-31 | Holzbaur LynetteSenior VP of Finance & Corporate Controller | -3.13k | 17.82k | Derivative Exercise and Sale | 5.70 | 26.40k | - |
| 2026-03-31 | Mr. Joseph T. MorrisseyCEO | 17.58k | 0.00 | Derivative Exercise and Retained Stock | - | 123.12k | 16.66% |
| 2026-03-31 | Mr. Joseph T. MorrisseyCEO | -7.01k | 39.93k | Derivative Exercise and Sale | 5.70 | 123.12k | - |
| 2026-03-29 | Ms. Rachel A. StahlerExec. VP, Chief Information Officer and Chief Digital & Growth Officer | 5.39k | 0.00 | Derivative Exercise and Retained Stock | - | 103.70k | 5.48% |
| 2026-03-29 | Ms. Rachel A. StahlerExec. VP, Chief Information Officer and Chief Digital & Growth Officer | -2.81k | 16.40k | Derivative Exercise and Sale | 5.84 | 103.70k | - |
| 2026-03-29 | Holzbaur LynetteSenior VP of Finance & Corporate Controller | -1.52k | 8.85k | Derivative Exercise and Sale | 5.84 | 18.56k | - |
| 2026-03-29 | Holzbaur LynetteSenior VP of Finance & Corporate Controller | 3.80k | 0.00 | Derivative Exercise and Retained Stock | - | 18.56k | 25.77% |
| 2026-03-29 | Mr. Daniel KarpChief Strategy Officer & Head of Corporate Development | -4.45k | 25.96k | Derivative Exercise and Sale | 5.84 | 57.15k | - |
| 2026-03-29 | Mr. Daniel KarpChief Strategy Officer & Head of Corporate Development | 9.74k | 0.00 | Derivative Exercise and Retained Stock | - | 57.15k | 20.54% |
| 2026-03-29 | Mr. Kirke WeaverExec. VP, General Counsel & Corporate Secretary | 5.55k | 0.00 | Derivative Exercise and Retained Stock | - | 79.40k | 7.51% |
| 2026-03-29 | Mr. Kirke WeaverExec. VP, General Counsel & Corporate Secretary | -2.21k | 12.91k | Derivative Exercise and Sale | 5.84 | 79.40k | - |
| 2026-03-29 | Mr. Vittorio NisitaExec. VP and Head of Enterprise Services & Solutions | 3.79k | 0.00 | Derivative Exercise and Retained Stock | - | 62.07k | 6.50% |
| 2026-03-29 | Mr. Vittorio NisitaExec. VP and Head of Enterprise Services & Solutions | -1.97k | 11.53k | Derivative Exercise and Sale | 5.84 | 62.07k | - |
| 2026-03-29 | Ms. Juliana Papa DrinaneHead of Manufacturing & Supply | 5.25k | 0.00 | Derivative Exercise and Retained Stock | - | 22.42k | 30.54% |
| 2026-03-29 | Ms. Juliana Papa DrinaneHead of Manufacturing & Supply | -2.73k | 15.96k | Derivative Exercise and Sale | 5.84 | 22.42k | - |
| 2026-03-29 | Dr. Juan Camilo Arjona FerreiraExec. VP, Head of Research & Development and Chief Medical Officer | -3.18k | 18.58k | Derivative Exercise and Sale | 5.84 | 21.44k | - |
| 2026-03-29 | Dr. Juan Camilo Arjona FerreiraExec. VP, Head of Research & Development and Chief Medical Officer | 5.68k | 0.00 | Derivative Exercise and Retained Stock | - | 21.44k | 36.08% |
| 2026-03-29 | Mr. Aaron FalcioneExec. VP & Chief HR Officer | 5.54k | 0.00 | Derivative Exercise and Retained Stock | - | 89.65k | 6.58% |
| 2026-03-29 | Mr. Aaron FalcioneExec. VP & Chief HR Officer | -2.89k | 16.85k | Derivative Exercise and Sale | 5.84 | 89.65k | - |
| 2026-03-29 | Mr. Matthew M. WalshExec. VP & CFO | 9.91k | 0.00 | Derivative Exercise and Retained Stock | - | 190.66k | 5.48% |
| 2026-03-29 | Mr. Matthew M. WalshExec. VP & CFO | -5.16k | 30.15k | Derivative Exercise and Sale | 5.84 | 190.66k | - |
| 2026-03-29 | Mr. Joseph T. MorrisseyCEO | 6.97k | 0.00 | Derivative Exercise and Retained Stock | - | 105.54k | 7.07% |
| 2026-03-29 | Mr. Joseph T. MorrisseyCEO | -2.78k | 16.23k | Derivative Exercise and Sale | 5.84 | 105.54k | - |
| 2026-02-27 | Mr. Aaron FalcioneExec. VP & Chief HR Officer | -11.01k | 79.05k | Sale to Issuer | 7.17 - 7.23 | 84.11k | -11.57% |
| 2026-02-27 | Mr. Matthew M. WalshExec. VP & CFO | -19.00k | 136.51k | Sale to Issuer | 7.17 - 7.23 | 180.75k | -9.51% |
| 2026-02-27 | Mr. Vittorio NisitaExec. VP and Head of Enterprise Services & Solutions | -7.79k | 55.91k | Sale to Issuer | 7.17 - 7.23 | 58.28k | -11.78% |
| 2026-02-27 | Ms. Rachel A. StahlerExec. VP, Chief Information Officer and Chief Digital & Growth Officer | -10.72k | 76.96k | Sale to Issuer | 7.17 - 7.23 | 98.31k | -9.83% |
| 2026-02-27 | Mr. Kirke WeaverExec. VP, General Counsel & Corporate Secretary | -8.58k | 61.61k | Sale to Issuer | 7.17 - 7.23 | 73.85k | -10.41% |
| 2026-02-27 | Mr. Joseph T. MorrisseyCEO | -10.27k | 73.77k | Sale to Issuer | 7.17 - 7.23 | 98.57k | -9.44% |
| 2025-11-07 | Ms. Juliana Papa DrinaneHead of Manufacturing & Supply | -1.24k | 8.33k | Sale to Issuer | 6.71 | 17.18k | -6.74% |
| 2025-11-12 | Ms. Carrie Smith CoxExecutive Chair of the Board | 65.40k | 501.76k | 買い | 7.67 | 77.87k | 524.50% |
| 2025-11-07 | Ms. Juliana Papa DrinaneHead of Manufacturing & Supply | 3.63k | 0.00 | Derivative Exercise and Retained Stock | - | 17.18k | 26.76% |
| 2025-11-07 | Dr. Juan Camilo Arjona FerreiraExec. VP, Head of Research & Development and Chief Medical Officer | 4.14k | 0.00 | Derivative Exercise and Retained Stock | - | 28.92k | 16.71% |
| 2025-11-07 | Dr. Juan Camilo Arjona FerreiraExec. VP, Head of Research & Development and Chief Medical Officer | -2.31k | 15.48k | Derivative Exercise and Sale | 6.71 | 28.92k | - |
| 2025-11-07 | Holzbaur LynetteSenior VP of Finance & Corporate Controller | 1.73k | 0.00 | Derivative Exercise and Retained Stock | - | 14.68k | 13.35% |
| 2025-11-07 | Holzbaur LynetteSenior VP of Finance & Corporate Controller | -689.00 | 4.62k | Derivative Exercise and Sale | 6.71 | 14.68k | - |
| 2025-11-05 | Holzbaur LynetteSenior VP of Finance & Corporate Controller | 2.17k | 0.00 | Derivative Exercise and Retained Stock | - | 12.95k | 20.14% |
| 2025-11-05 | Holzbaur LynetteSenior VP of Finance & Corporate Controller | -866.00 | 5.65k | Derivative Exercise and Sale | 6.52 | 12.95k | - |
| 2025-08-11 | Dr. Juan Camilo Arjona FerreiraExec. VP, Head of Research & Development and Chief Medical Officer | 7.40k | 0.00 | Derivative Exercise and Retained Stock | - | 24.78k | 42.56% |
| 2025-08-11 | Dr. Juan Camilo Arjona FerreiraExec. VP, Head of Research & Development and Chief Medical Officer | -4.12k | 38.00k | Derivative Exercise and Sale | 9.22 | 24.78k | - |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
